Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mebendazole; from an anti-parasitic drug to a promising candidate for drug repurposing in colorectal cancer
Sahar K. Hegazy, Gamal A. El-Azab, Fatma Zakaria, et al.
Life Sciences (2022) Vol. 299, pp. 120536-120536
Closed Access | Times Cited: 16

Showing 16 citing articles:

Emerging Perspectives on the Antiparasitic Mebendazole as a Repurposed Drug for the Treatment of Brain Cancers
Daniela Meco, Giorgio Attinà, Stefano Mastrangelo, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1334-1334
Open Access | Times Cited: 31
Current trends and future prospects of drug repositioning in gastrointestinal oncology
Nayeralsadat Fatemi, Mina Karimpour, Hoda Bahrami, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 6
Drug Repurposing in Oncology: A Systematic Review of Randomized Controlled Clinical Trials
Ignatios Ioakeim‐Skoufa, Natalia Tobajas-Ramos, Enrica Menditto, et al.
Cancers (2023) Vol. 15, Iss. 11, pp. 2972-2972
Open Access | Times Cited: 14
A Review of Potential Agents for Colon Cancer Interception in FAP Patients: Evidence from Preclinical Studies in APCMin/+ Mice
Karthikkumar Venkatachalam, Krishnendu Goswami, Venkateshwar Madka, et al.
Targets (2025) Vol. 3, Iss. 1, pp. 4-4
Open Access
Computational drug discovery approaches identify mebendazole as a candidate treatment for autosomal dominant polycystic kidney disease
Philip W. Brownjohn, Azedine Zoufir, Daniel J. O’Donovan, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
TNIK in disease: from molecular insights to therapeutic prospects
Xue Wu, Zhe Zhang, Zhenye Qiu, et al.
APOPTOSIS (2024) Vol. 29, Iss. 9-10, pp. 1361-1376
Closed Access | Times Cited: 2
Drug Repurposing in Pediatric Brain Tumors: Posterior Fossa Ependymoma and Diffuse Midline Glioma under the Looking Glass
Tiziana Servidei, Alessandro Sgambato, Donatella Lucchetti, et al.
Frontiers in Bioscience-Landmark (2023) Vol. 28, Iss. 4
Open Access | Times Cited: 5
Structural Changes, Biological Consequences, and Repurposing of Colchicine Site Ligands
Felipe Montecinos-Franjola, Dan L. Sackett
Biomolecules (2023) Vol. 13, Iss. 5, pp. 834-834
Open Access | Times Cited: 5
Benzimidazole carbamate induces cytotoxicity in breast cancer cells via two distinct cell death mechanisms
Brendan Graff, Chitra Palanivel, Christopher B. Jenkins, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 5
Phase II, Double-Blinded, Randomized, Placebo-Controlled Clinical Trial Investigating the Efficacy of Mebendazole in the Management of Symptomatic COVID-19 Patients
Mohamed El‐Tanani, Khaled Abdul‐Aziz Ahmed, Ashok K. Shakya, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 6, pp. 799-799
Open Access | Times Cited: 5
Targeting the Unwindosome by Mebendazole Is a Vulnerability of Chemoresistant Hepatoblastoma
Qian Li, Salih Demir, Álvaro Del Río-Álvarez, et al.
Cancers (2022) Vol. 14, Iss. 17, pp. 4196-4196
Open Access | Times Cited: 4
In vitro and in vivo anticancer activity of mebendazole in colon cancer: a promising drug repositioning
Amin Aliabadi, Mohammad Reza Haghshenas, Razie Kiani, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2023) Vol. 397, Iss. 4, pp. 2379-2388
Closed Access | Times Cited: 2
Behavior of Mebendazole during NF/RO Adsorption and Photolysis
Bruna Babić, Darko Andrić, Anamarija Farkaš, et al.
Membranes (2022) Vol. 12, Iss. 9, pp. 888-888
Open Access | Times Cited: 3
Structures and biological activity of three 2-(pyridin-2-yl)-1H-benzimidazole derivatives
Jarosław Sukiennik, Andrzej Ołczak, Katarzyna Gobis, et al.
Acta Crystallographica Section C Structural Chemistry (2023) Vol. 79, Iss. 12, pp. 504-512
Closed Access | Times Cited: 1
Repurposing Drugs for Overcoming Therapy Resistance in Colon Cancer – A Review
Mahdi Darvishi, Amir Chekeni, Mohammad Fazelhosseini, et al.
Journal of Angiotherapy (2024) Vol. 8, Iss. 2
Open Access
The m6A reader IGF2BP1 contributes to the activation of hepatic stellate cells through facilitating TUBB4B mRNA stabilization
Yanshan Li, Ling Chen, Shuyi Li, et al.
Journal of Gastroenterology and Hepatology (2024)
Open Access
Page 1

Scroll to top